Kai Pharmaceuticals

This study tested whether a drug called KAI-1678 can reduce pain in people with spinal cord injury. Five adults with long-term spinal cord injury and ongoing nerve pain received either the drug or a placebo. The goal was to see if the drug lowered pain intensity within 6 hours.

This study tested whether a single injection of KAI-1678 can reduce pain in people with postherpetic neuralgia, a type of nerve pain that lingers after a shingles outbreak. Twenty-three adults with moderate to severe pain received either the study drug, a placebo, or an active pa…